Pesquisar





Pesquisar





Mercados
/
Ações
/
nasdaq-sdgr
/

Schrodinger Inc

SDGR

Adicionar à lista de desejos

12.690USD

-0.030-0.24%

Fechamento 05/12, 16:00（ET）Cotações atrasadas em 15 min

948.21MValor de mercado

PerdaP/L TTM



Schrodinger Inc

12.690

-0.030-0.24%

Visão Geral Serviços Financeiros Discussões Análises Empresa

Visão Geral

Serviços Financeiros

Discussões

Análises

Empresa

Mais detalhes de Schrodinger Inc Empresa

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.

Informações de Schrodinger Inc



Código da empresaSDGR

Nome da EmpresaSchrodinger Inc

Data de listagemFeb 06, 2020

CEOFarid (Ramy Farid)

Número de funcionários891

Tipo de títulosOrdinary Share

Fim do ano fiscalFeb 06

Endereço1540 Broadway

CidadeNEW YORK

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal10036

Telefone15032991150

Sitehttps://www.schrodinger.com

Código da empresaSDGR

Data de listagemFeb 06, 2020

CEOFarid (Ramy Farid)

Executivos da empresa Schrodinger Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Richard A. Friesner, Ph.D.

Director

1.40M

+0.19%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

72.66K

+50.36%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

24.57K

-5.68%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

11.25K

-8.86%

Mr. Arun Oberoi

Independent Director

11.25K

-8.86%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

10.49K

-402.13%

Ms. Bridget Anne Van Kralingen

Independent Director

3.33K

-245.00%

Dr. Ramy Farid, Ph.D.

President, Chief Executive Officer, Director

Dr. Robert Abel, Ph.D.

Executive Vice President, Chief Scientific Officer, Platform

Dr. Karen Akinsanya, Ph.D.

President - R&D Therapeutics

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Richard A. Friesner, Ph.D.

Director

1.40M

+0.19%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

72.66K

+50.36%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

24.57K

-5.68%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

11.25K

-8.86%

Mr. Arun Oberoi

Independent Director

11.25K

-8.86%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

10.49K

-402.13%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

On-premise software

101.45M

39.65%

Drug discovery services

54.76M

21.40%

Hosted software

45.12M

17.64%

Software maintenance

27.29M

10.67%

Contribution

15.99M

6.25%

Outro

11.26M

4.40%

Por RegiãoUSD

Nome

Receita

Proporção

United States

152.96M

59.78%

EMEA

75.16M

29.38%

APAC

26.18M

10.23%

Rest of World

1.56M

0.61%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

On-premise software

101.45M

39.65%

Drug discovery services

54.76M

21.40%

Hosted software

45.12M

17.64%

Software maintenance

27.29M

10.67%

Contribution

15.99M

6.25%

Outro

11.26M

4.40%

Distribuição de ações

Atualizado em: seg, 11 de mai

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

12.36%

Bill & Melinda Gates Foundation Trust

10.65%

Rubric Capital Management LP

6.36%

Vanguard Portfolio Management, LLC

5.89%

Amova Asset Management Co., Ltd.

4.87%

Outro

59.87%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

12.36%

Bill & Melinda Gates Foundation Trust

10.65%

Rubric Capital Management LP

6.36%

Vanguard Portfolio Management, LLC

5.89%

Amova Asset Management Co., Ltd.

4.87%

Outro

59.87%

Tipos de investidores

Investidores

Proporção

Investment Advisor

42.81%

Investment Advisor/Hedge Fund

26.30%

Hedge Fund

12.61%

Endowment Fund

10.65%

Individual Investor

3.00%

Research Firm

2.77%

Bank and Trust

2.11%

Pension Fund

0.76%

Private Equity

0.31%

Participação acionária institucional



Atualizado em: qua, 1 de abr

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2026Q1

525

71.93M

109.89%

-7.22M

2025Q4

534

70.89M

109.90%

-7.48M

2025Q3

545

71.77M

111.28%

-2.08M

2025Q2

572

66.46M

103.14%

-5.60M

2025Q1

593

67.21M

104.69%

-5.43M

2024Q4

576

64.44M

100.89%

-9.04M

2024Q3

581

67.44M

105.91%

-6.15M

2024Q2

573

64.76M

101.80%

-8.12M

2024Q1

574

63.48M

100.05%

-5.40M

2023Q4

584

62.06M

98.56%

-7.64M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

8.10M

12.53%

+9.48K

+0.12%

Dec 31, 2025

Bill & Melinda Gates Foundation Trust

6.98M

10.8%

Dec 31, 2025

Rubric Capital Management LP

4.17M

6.45%

-1.10M

-20.83%

Dec 31, 2025

Amova Asset Management Co., Ltd.

4.71M

7.29%

+160.20K

+3.52%

Dec 31, 2025

MFS Investment Management

2.29M

3.54%

+218.92K

+10.56%

Dec 31, 2025

Lazard Asset Management, L.L.C.

2.13M

3.3%

-211.47K

-9.01%

Dec 31, 2025

State Street Investment Management (US)

2.13M

3.3%

-73.13K

-3.32%

Dec 31, 2025

ARK Investment Management LLC

2.11M

3.27%

+239.15K

+12.77%

Dec 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

ARK Genomic Revolution ETF

3.63%

Clough Select Equity ETF

3.12%

TrueShares Technology, AI & Deep Learning ETF

1.99%

Global X HealthTech ETF

1.14%

State Street SPDR FactSet Innovative Technolgy ETF

0.84%

Franklin Exponential Data ETF

0.82%

WisdomTree BioRevolution Fund

0.77%

Invesco S&P SmallCap Health Care ETF

0.72%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.47%

First Trust Multi-Manager Small Cap Opportunities ETF

0.47%

Ver Mais

ARK Genomic Revolution ETF

Proporção3.63%

Clough Select Equity ETF

Proporção3.12%

TrueShares Technology, AI & Deep Learning ETF

Proporção1.99%

Global X HealthTech ETF

Proporção1.14%

State Street SPDR FactSet Innovative Technolgy ETF

Proporção0.84%

Franklin Exponential Data ETF

Proporção0.82%

WisdomTree BioRevolution Fund

Proporção0.77%

Invesco S&P SmallCap Health Care ETF

Proporção0.72%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção0.47%

First Trust Multi-Manager Small Cap Opportunities ETF

Proporção0.47%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados

KeyAI

